What are the consequences for veterinary immunological products and how may this impact on their development for registration if the regulation would be applied as currently proposed?  Dr Regina Wolf and Dr Klaus Hellmann of klifovet discuss new regulations, compare them to previous legislative solutions and analyse its different interpretations and possibilities.